World Wires · story 98389 · unverified · 1 source(s)

First Human Administration of Senolytic Immunotherapy to Fight Cellular Aging Announced by Immorta Bio

First patient receives SenoMune™-0257, a pioneering immunotherapy designed to eliminate aging cells and advance treatment of age-related diseases MIAMI, No

Open in the desk

Coverage

What this site indexes